Stock PGHL PROCTER & GAMBLE HEALTH LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Procter & Gamble Health Limited

Equities

PGHL

INE199A01012

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 11:00:48 30/04/2024 BST 		5-day change 1st Jan Change
4,916 INR +2.97% Intraday chart for Procter & Gamble Health Limited +4.59% -0.60%
02-06 Procter & Gamble Health Limited Declares Interim Dividend for the Financial Year 2023-24, Payable on or Before March 3, 2024 CI
02-06 Procter & Gamble Health Limited Declares Special Dividend for the Financial Year 2023-24, Payable on or Before March 3, 2024 CI

Valuation

Fiscal Period: Juni 2018 2020 2021 2022 2023
Capitalization 1 39,336 67,513 92,857 69,507 87,133
Enterprise Value (EV) 1 26,901 61,122 88,293 66,341 82,903
P/E ratio 4.69 x 40.7 x 52.5 x 36.1 x 38 x
Yield 1.01% 0.69% 0.72% 1.25% 1.81%
Capitalization / Revenue 4.63 x 7.6 x 9.21 x 6.24 x 7.09 x
EV / Revenue 3.17 x 6.88 x 8.75 x 5.95 x 6.74 x
EV / EBITDA 17.7 x 29.3 x 36.2 x 25.1 x 26 x
EV / FCF 16.6 x - 49.3 x 56.6 x 48.3 x
FCF Yield 6.01% - 2.03% 1.77% 2.07%
Price to Book 2.55 x 7.45 x 13.2 x 11.3 x 11.6 x
Nbr of stocks (in thousands) 16,599 16,599 16,599 16,599 16,599
Reference price 2 2,370 4,067 5,594 4,187 5,249
Announcement Date 08/05/19 03/11/20 17/10/21 31/10/22 23/08/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Juni 2018 2020 2021 2022 2023
Net sales 1 8,490 8,886 10,087 11,144 12,296
EBITDA 1 1,517 2,088 2,441 2,648 3,188
EBIT 1 1,270 1,892 2,188 2,426 2,958
Operating Margin 14.96% 21.29% 21.69% 21.77% 24.06%
Earnings before Tax (EBT) 1 1,580 2,199 2,333 2,534 3,142
Net income 1 8,387 1,659 1,768 1,925 2,295
Net margin 98.79% 18.67% 17.53% 17.28% 18.66%
EPS 2 505.3 99.87 106.5 116.0 138.0
Free Cash Flow 1 1,617 - 1,789 1,172 1,716
FCF margin 19.05% - 17.74% 10.51% 13.95%
FCF Conversion (EBITDA) 106.58% - 73.31% 44.25% 53.83%
FCF Conversion (Net income) 19.28% - 101.2% 60.86% 74.77%
Dividend per Share 2 24.00 28.00 40.00 52.50 95.00
Announcement Date 08/05/19 03/11/20 17/10/21 31/10/22 23/08/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: Juni 2018 2020 2021 2022 2023
Net Debt 1 - - - - -
Net Cash position 1 12,434 6,391 4,564 3,166 4,231
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow 1 1,617 - 1,789 1,172 1,716
ROE (net income / shareholders' equity) 8.95% - 22% 29.2% 33.6%
ROA (Net income/ Total Assets) 5.77% - 12.7% 16.1% 18.6%
Assets 1 145,293 - 13,973 11,937 12,344
Book Value Per Share 2 928.0 546.0 424.0 371.0 452.0
Cash Flow per Share 2 749.0 385.0 280.0 192.0 262.0
Capex 1 267 155 526 379 425
Capex / Sales 3.15% 1.75% 5.21% 3.4% 3.45%
Announcement Date 08/05/19 03/11/20 17/10/21 31/10/22 23/08/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

1st Jan change Capi.
PROCTER & GAMBLE HEALTH LIMITED Stock Procter & Gamble Health Limited
-0.60% 978M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+19.27% 43.18B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+24.05% 23.23B
SANDOZ GROUP AG Stock Sandoz Group AG
+15.11% 14.6B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+38.36% 11.5B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-7.63% 6.79B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+10.21% 5.31B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. Stock Shenzhen Salubris Pharmaceuticals Co., Ltd.
-2.27% 4.81B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. PGHL Stock
  4. Financials Procter & Gamble Health Limited